Today: 29 April 2026
Browse Category

NYSE:RDN 14 January 2026 - 21 March 2026

Rocket Companies Stock Falls 7% as Mortgage Rates Hit 3-Month High, Wiping Out Upgrade Rally

Rocket Companies Stock Falls 7% as Mortgage Rates Hit 3-Month High, Wiping Out Upgrade Rally

Rocket Companies shares fell 6.8% to $13.65 Friday, underperforming other mortgage stocks as U.S. mortgage rates climbed to 6.22%. The drop followed an analyst upgrade and recent strong revenue guidance. Wall Street broadly declined amid inflation and rate hike concerns. Rocket ended below its post-upgrade close of $14.76.
21 March 2026
·······
Rocket Companies stock sinks nearly 14% (RKT) — what’s driving the slide and what comes next

Rocket Companies stock sinks nearly 14% (RKT) — what’s driving the slide and what comes next

Rocket Companies fell 13.7% to $17.93 Friday, with trading volume tripling its 50-day average. Mortgage lenders slid after PennyMac missed profit targets and dropped 33%, citing tighter loan margins. The 10-year Treasury yield neared 4.25% as markets reacted to Kevin Warsh’s Fed nomination. Investors await U.S. jobs data and mortgage figures next week.
31 January 2026
·····
Mortgage rates today: Rocket stock slips as 30-year fixed moves back above 6%

Mortgage rates today: Rocket stock slips as 30-year fixed moves back above 6%

Rocket Companies shares fell 1.9% to $22.76 in early Wednesday trading as the average 30-year fixed mortgage rate climbed to 6.07%. Mortgage lenders and insurers, including loanDepot and MGIC Investment, also dropped. U.S. consumer prices rose 2.7% in December, keeping traders focused on inflation and upcoming economic data. Investors are watching for fresh mortgage-application numbers and inflation reports later in the day.
14 January 2026
······

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:49 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop